Product Information
ZOLMITRIPTAN 5 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $1.4918 per EA under NDC 65862091564. Its NADAC has been published 408 times since May 17, 2017.
Strength
5 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862091564
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
2/19/2025
Active Ingredients
ZOLMITRIPTANApproval Type
Generic (ANDA)
FDA Application
ANDA207021On Market Since
5/11/2016
Pharmacological Classes
Price Statistics
The NADAC for ZOLMITRIPTAN 5 MG TABLET has been published 408 times since May 17, 2017, and over the history we have for it it has declined 81.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.4918 per EA |
|---|---|
| All-time high | $8.2629 (Jun 14, 2017) |
| All-time low | $1.1137 (May 22, 2024) |
| Median price | $1.9399 |
| Average price | $3.1280 |
| Largest weekly change | -55.4% (Feb 19, 2020) |
| Weeks tracked | 408 |
| Tracking since | May 17, 2017 |
Generic Alternatives
The matcher finds 11 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ZOLMITRIPTAN 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ZOLMITRIPTAN 5 MG TABLET, manufactured by Aurobindo Pharma Limited, is $1.4918 per EA (NDC 65862091564), effective Mar 5, 2025.
How has the price of ZOLMITRIPTAN 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ZOLMITRIPTAN 5 MG TABLET has declined 81.9%. It has been tracked across 408 weekly CMS publications since May 17, 2017.
What are the highest and lowest recorded NADAC prices for ZOLMITRIPTAN 5 MG TABLET?
Since May 17, 2017, the NADAC for ZOLMITRIPTAN 5 MG TABLET has ranged from a low of $1.1137 (May 22, 2024) to a high of $8.2629 (Jun 14, 2017), with a median of $1.9399 per EA.
Are there cheaper alternatives to ZOLMITRIPTAN 5 MG TABLET?
Yes. 11 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, ZOLMITRIPTAN 5 MG TABLET, is $1.4228 per EA — about 5% below ZOLMITRIPTAN 5 MG TABLET.
Who manufactures ZOLMITRIPTAN 5 MG TABLET?
ZOLMITRIPTAN 5 MG TABLET (NDC 65862091564) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification